Salix Pharmaceuticals (SLXP) will Flounder ahead of Visibility on Relistor - Jefferies
Tweet Send to a Friend
Jefferies analysts reiterated a Buy on Salix Pharmaceuticals (NASDAQ: SLXP), but cut their price target to $58.00 (from $63.00).
This article: 260 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 260 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
